BiFlow Medical is the developer of a minimally invasive therapy for abnormal aortic aneurysm (AAA). The company has developed a mechanism that integrates two unique stents, the side-branch stent and the extension graft stent, for those diagnosed with critical abdominal aortic aneurysms (AAA), which can be repaired only with surgery. BiFlows side-branch stent provides an extension of the aorta graft stent, enabling blood flow through the renal artery and thereby increasing the number of patients who can undergo EVAR. BiFlows vision is to replace abdominal aorta aneurysm (AAA) surgeries with regular endovascular repair.